This inventor holds 1 USPTO granted patent. Top assignee: Antartina LLC. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Guillermo Mazzolini: Innovator in Therapeutic Molecules
Introduction
Guillermo Mazzolini is a notable inventor based in Escobar, Argentina. He has made significant contributions to the field of therapeutic molecules, particularly in the area of colorectal carcinoma treatment. His innovative work has the potential to impact cancer therapies positively.
Latest Patents
Mazzolini holds a patent for therapeutic molecules and derivatives for colorectal cancer (CRC). The patent describes a chemically synthesized compound, Tricin 7-O-beta-D-glucopyranoside, which is native to certain plants. This compound has demonstrated the ability to inhibit tumor growth in mammals suffering from colorectal carcinoma.
Career Highlights
Guillermo Mazzolini is associated with Antartina LLC, where he continues to develop and refine his research in therapeutic applications. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Mazzolini has collaborated with notable colleagues, including Manuel Gidekel and Julio Alvarez Builla. These partnerships have fostered a collaborative environment that enhances the research and development of innovative therapeutic solutions.
Conclusion
Guillermo Mazzolini's contributions to the field of therapeutic molecules exemplify the impact of innovative research on cancer treatment. His work continues to inspire advancements in medical science and offers hope for improved therapies for colorectal carcinoma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile